Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes

Chest. 2012 Jul;142(1):15-17. doi: 10.1378/chest.12-1085.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Catheters, Indwelling
  • Cost-Benefit Analysis
  • Humans
  • Pleural Effusion, Malignant / therapy*
  • Pleurodesis / economics
  • Pleurodesis / methods*
  • Quality of Life
  • Recurrence
  • Talc / administration & dosage*
  • Thoracoscopy / economics
  • Thoracoscopy / methods*
  • Thoracostomy
  • Treatment Outcome

Substances

  • Talc